Acknowledgements
We thank all members of the Zhejiang Key Laboratory of Diagnosis and Treatment for Hematologic Malignancies to provide supports for diagnosis. The whole-exome-sequencing was supported by Acornmed Company (Beijing, China) and the RNA-sequencing was supported by Annoroad Company (Beijing, China).
Disclosure statement
No potential conflict of interest was reported by the author(s).